1.Quantitative Proteomic Analysis Reveals Impaired Axonal Guidance Signaling in Human Postmortem Brain Tissues of Chronic Traumatic Encephalopathy
Baibin BI ; Han Pil CHOI ; Seung Jae HYEON ; Shengnan SUN ; Ning SU ; Yuguang LIU ; Junghee LEE ; Neil W KOWALL ; Ann C MCKEE ; Jing Hua YANG ; Hoon RYU
Experimental Neurobiology 2019;28(3):362-375
Chronic traumatic encephalopathy (CTE) is a distinct neurodegenerative disease that associated with repetitive head trauma. CTE is neuropathologically defined by the perivascular accumulation of abnormally phosphorylated tau protein in the depths of the sulci in the cerebral cortices. In advanced CTE, hyperphosphorylated tau protein deposits are found in widespread regions of brain, however the mechanisms of the progressive neurodegeneration in CTE are not fully understood. In order to identify which proteomic signatures are associated with CTE, we prepared RIPA-soluble fractions and performed quantitative proteomic analysis of postmortem brain tissue from individuals neuropathologically diagnosed with CTE. We found that axonal guidance signaling pathwayrelated proteins were most significantly decreased in CTE. Immunohistochemistry and Western blot analysis showed that axonal signaling pathway-related proteins were down regulated in neurons and oligodendrocytes and neuron-specific cytoskeletal proteins such as TUBB3 and CFL1 were reduced in the neuropils and cell body in CTE. Moreover, oligodendrocyte-specific proteins such as MAG and TUBB4 were decreased in the neuropils in both gray matter and white matter in CTE, which correlated with the degree of axonal injury and degeneration. Our findings indicate that deregulation of axonal guidance proteins in neurons and oligodendrocytes is associated with the neuropathology in CTE. Together, altered axonal guidance proteins may be potential pathological markers for CTE.
Axons
;
Blotting, Western
;
Brain Injury, Chronic
;
Brain
;
Cell Body
;
Cerebral Cortex
;
Craniocerebral Trauma
;
Cytoskeletal Proteins
;
Gray Matter
;
Humans
;
Immunohistochemistry
;
Neurodegenerative Diseases
;
Neurons
;
Neuropathology
;
Neuropil
;
Oligodendroglia
;
tau Proteins
;
White Matter
2.Transcriptome analyses of chronic traumatic encephalopathy show alterations in protein phosphatase expression associated with tauopathy.
Jeong Sun SEO ; Seungbok LEE ; Jong Yeon SHIN ; Yu Jin HWANG ; Hyesun CHO ; Seong Keun YOO ; Yunha KIM ; Sungsu LIM ; Yun Kyung KIM ; Eun Mi HWANG ; Su Hyun KIM ; Chong Hyun KIM ; Seung Jae HYEON ; Ji Young YUN ; Jihye KIM ; Yona KIM ; Victor E ALVAREZ ; Thor D STEIN ; Junghee LEE ; Dong Jin KIM ; Jong Il KIM ; Neil W KOWALL ; Hoon RYU ; Ann C MCKEE
Experimental & Molecular Medicine 2017;49(5):e333-
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disorder that is associated with repetitive head injury and has distinctive neuropathological features that differentiate this disease from other neurodegenerative diseases. Intraneuronal tau aggregates, although they occur in different patterns, are diagnostic neuropathological features of CTE, but the precise mechanism of tauopathy is not known in CTE. We performed whole RNA sequencing analysis of post-mortem brain tissue from patients with CTE and compared the results to normal controls to determine the transcriptome signature changes associated with CTE. The results showed that the genes related to the MAP kinase and calcium-signaling pathways were significantly downregulated in CTE. The altered expression of protein phosphatases (PPs) in these networks further suggested that the tauopathy observed in CTE involves common pathological mechanisms similar to Alzheimer's disease (AD). Using cell lines and animal models, we also showed that reduced PPP3CA/PP2B phosphatase activity is directly associated with increases in phosphorylated (p)-tau proteins. These findings provide important insights into PP-dependent neurodegeneration and may lead to novel therapeutic approaches to reduce the tauopathy associated with CTE.
Alzheimer Disease
;
Brain
;
Brain Injury, Chronic*
;
Cell Line
;
Craniocerebral Trauma
;
Gene Expression Profiling*
;
Humans
;
Models, Animal
;
Neurodegenerative Diseases
;
Phosphoprotein Phosphatases
;
Phosphotransferases
;
Sequence Analysis, RNA
;
Tauopathies*
;
Transcriptome*